ID: 20	RANK: 44	SCORE: 16.8060



<DOC>
<DOCNO> FR940705-2-00181 </DOCNO>
<PARENT> FR940705-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section V&hyph;K. C. M. Collins, E. G. Hartley, and R. Pilsworth, The Prevention of 
<!-- PJG 0012 frnewline -->
Laboratory Acquired Infection, Public Health Laboratory Service, Monograph Series 
<!-- PJG 0012 frnewline -->
No. 6, 1974. 
<!-- PJG 0012 frnewline -->
Section V&hyph;L. Chatigny, M. A, ``Protection Against Infection in the Microbiological 
<!-- PJG 0012 frnewline -->
Laboratory: Devices and Procedures,'' in W.W. Umbreit (ed.), Advances in Applied 
<!-- PJG 0012 frnewline -->
Microbiology, Academic Press, New York, New York, 1961, 3:131&hyph;192. 
<!-- PJG 0012 frnewline -->
Section V&hyph;M.  Design Criteria for Viral Oncology Research Facilities, U.S. Department 
<!-- PJG 0012 frnewline -->
of Health, Education, and Welfare, Public Health Service, NIH, DHEW Publication 
<!-- PJG 0012 frnewline -->
No. (NIH) 75&hyph;891, 1975. 
<!-- PJG 0012 frnewline -->
Section V&hyph;N. Kuehne, R. W., Biological Containment Facility for Studying Infectious 
<!-- PJG 0012 frnewline -->
Disease, Appl. Microbiol. 26:239&hyph;243, 1973. 
<!-- PJG 0012 frnewline -->
Section V&hyph;O. Runkle, R. B., and G. B. Phillips, Microbial Containment Control 
<!-- PJG 0012 frnewline -->
Facilities, Van Nostrand Reinhold, New York, 1969. 
<!-- PJG 0012 frnewline -->
Section V&hyph;P. Chatigny, M. A., and D. I. Clinger, ``Contamination Control in 
<!-- PJG 0012 frnewline -->
Aerobiology,'' in R. L. Dimmick and A. B. Akers (eds.), An Introduction to 
<!-- PJG 0012 frnewline -->
Experimental Aerobiology, John Wiley &amp; Sons, New York, 1969, pp. 194&hyph;263. 
<!-- PJG 0012 frnewline -->
Section V&hyph;Q. As classified in the Third Report of the International Committee on 
<!-- PJG 0012 frnewline -->
Taxonomy of Viruses: Classification and Nomenclature of Viruses, R. E. F. Matthews 
<!-- PJG 0012 frnewline -->
(ed.), Intervirology 12 (129&hyph;296), 1979. 
<!-- PJG 0012 frnewline -->
Section V&hyph;R. A U.S. Department of Agriculture permit is required for the 
<!-- PJG 0012 frnewline -->
importation, interstate movement, and release into the environment of certain 
<!-- PJG 0012 frnewline -->
organisms that are plant or animal pathogens, whether genetically engineered or 
<!-- PJG 0012 frnewline -->
not. Permits are required for veterinary biologics and for certain plants or 
<!-- PJG 0012 frnewline -->
microorganisms derived through genetic engineering using genetic sequences from 
<!-- PJG 0012 frnewline -->
plant pests (pathogens). Specific information about regulated organisms and 
<!-- PJG 0012 frnewline -->
procedures for obtaining a permit for regulated organisms may be obtained from the 
<!-- PJG 0012 frnewline -->
Director, Biotechnology, Biologics, and Environmental Protection, Animal and Plant 
<!-- PJG 0012 frnewline -->
Health Inspection Service, U.S. Department of Agriculture, 6505 Belcrest Road, 
<!-- PJG 0012 frnewline -->
Room 850, Hyattsville, Maryland 20782, (301) 436&hyph;7601. 
<!-- PJG 0012 frnewline -->
Section V&hyph;S. i.e., the total of all genomes within a family shall not exceed two-thirds 
<!-- PJG 0012 frnewline -->
of the genome. 
<!-- PJG 0012 frnewline -->
Section V&hyph;T. All activities, including storage of variola and whitepox, are restricted 
<!-- PJG 0012 frnewline -->
to the single national facility (World Health Organization Collaborating Center for 
<!-- PJG 0012 frnewline -->
Smallpox Research, Centers for Disease Control and Prevention, Atlanta, Georgia). 
<!-- PJG 0012 frnewline -->
Section V&hyph;U. Human studies in which the induction or enhancement of an immune 
<!-- PJG 0012 frnewline -->
response to a vector-encoded microbial immunogen is the major goal, such an 
<!-- PJG 0012 frnewline -->
immune response has been demonstrated in model systems, and the persistence of 
<!-- PJG 0012 frnewline -->
the vector-encoded immunogen is not expected, are not covered under Sections 
<!-- PJG 0012 frnewline -->
III&hyph;A&hyph;2, III&hyph;B&hyph;2, or III&hyph;B&hyph;3. Such studies may be initiated without RAC review
and 
<!-- PJG 0012 frnewline -->
NIH approval if approved by another Federal agency. 
<!-- PJG 0012 frnewline -->
Section V&hyph;V. For recombinant DNA experiments in which the intent is to modify 
<!-- PJG 0012 frnewline -->
stably the genome of cells of one or more human subjects (see Sections III&hyph;A&hyph;2, III&hyph;B&hyph;2, and
III&hyph;B&hyph;3). 
<!-- PJG 0012 frnewline -->
Section V&hyph;W. In accordance with accepted scientific and regulatory practices of the 
<!-- PJG 0012 frnewline -->
discipline of plant pathology, an exotic plant pathogen (e.g., virus, bacteria, or 
<!-- PJG 0012 frnewline -->
fungus) is one that is unknown to occur within the U.S. (see Section V&hyph;R). 
<!-- PJG 0012 frnewline -->
Determination of whether a pathogen has a potential for serious detrimental impact 
<!-- PJG 0012 frnewline -->
on managed (agricultural, forest, grassland) or natural ecosystems should be made 
<!-- PJG 0012 frnewline -->
by the Principal Investigator and the Institutional Biosafety Committee, in 
<!-- PJG 0012 frnewline -->
consultation with scientists knowledgeable of plant diseases, crops, and ecosystems 
<!-- PJG 0012 frnewline -->
in the geographic area of the research. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix A. Exemptions Under Section III&hyph;E&hyph;5_Sublists of 
<!-- PJG 0012 frnewline -->
Natural Exchangers 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>
